CGC Deadline: CGC Investors with Losses in Excess of $100K Have Opportunity to Lead Canopy Growth Corporation Securities Fraud Lawsuit
- The Rosen Law Firm reminded purchasers of Canopy Growth Corporation securities of the lead plaintiff deadline on June 3, 2025, for a class action lawsuit filed in New York.
- This reminder is directed at investors who purchased shares of Canopy Growth Corporation during the specified timeframe from late May 2024 through early February 2025, which defines the relevant class period for this legal case.
- The lawsuit alleges that Canopy Growth made false or misleading statements and failed to disclose significant costs linked to Claybourne pre-rolled joints and vaporizer devices, affecting the company’s financial results.
- Rosen Law Firm, known for securing over $438 million in 2019 and recognized for top securities class action settlements, stated that affected investors may obtain compensation through a contingency fee without paying upfront costs.
- Investors interested in becoming the lead plaintiff need to file a motion with the Court by June 3, 2025, a deadline that could impact who leads the lawsuit and the distribution of any potential recovery.
40 Articles
40 Articles


CGC IMPORTANT DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Canopy Growth ...
NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -

CGC Deadline: CGC Investors with Losses in Excess of $100K Have Opportunity to Lead Canopy Growth Corporation Securities Fraud Lawsuit
NEW YORK, May 30, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Canopy Growth Corporation (NASDAQ: CGC) between May 30, 2024 and February 6, 2025, both dates inclusive (the "Class Period"),…
Why Canopy Growth Stock Crashed on Friday @themotleyfool #stocks $CGC
Canopy Growth (NASDAQ: CGC) stock collapsed in morning trading Friday, down 20.5% through 11 a.m. ET after the company reported a comically bad earnings miss. Heading into today's report, analysts forecast the Canadian cannabis company would lose $0.20 per share in its fourth quarter of fiscal 2025. Instead, Canopy Growth reported a loss of (better sit down for this) $1.32 per share. Where to invest $1,000 right now? Our analyst team just reveal…
Canopy Growth cuts debt and losses, refocuses on medical cannabis
LAURIE WEIR Cannabis producer Canopy Growth says it’s making headway on a turnaround, reporting smaller losses and a nearly 50 per cent reduction in debt as it refocuses on medical cannabis and trims costs. For the fiscal year ending March 31, 2025, Canopy brought in $269 million in revenue — down 9 per cent from last year — but reduced its net loss from continuing operations to $604 million, an improvement over the $804 million lost the year be…
Coverage Details
Bias Distribution
- 56% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage